Trials / Completed
CompletedNCT04441229
Mobile Attentional Bias Modification Training in Pediatric MS
A Prospective, Observational Study of Mobile Attentional Bias Modification Training (ABMT) in the Pediatric Multiple Sclerosis (MS) Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 12 Years – 24 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT application sessions. Subjects will complete online REDCap or MyCap surveys weekly and at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ABMT mobile application | After consent/assent, participants will complete 1 hour-long, in-person or remote, baseline study visit at the Multiple Sclerosis Comprehensive Care Center. During this visit, participants will complete baseline study surveys and a brief computerized attention bias assessment and be trained on the use of the ABMT mobile application. Participants will then complete at-home game play 4 days a week, for 30 days, using an iOS mobile device, approximately 10-15 minutes each day. Subjects will complete weekly online study surveys via REDCap or MyCap (Mobile REDCap Application). At the conclusion of participation, participants will complete online end of study surveys via REDCap or MyCap. Parents of participants will complete surveys at the baseline visit, followed by online surveys at Week 2 and at the end of study. For participants who are 18 years old or older, parental participation will not be required. |
Timeline
- Start date
- 2020-06-12
- Primary completion
- 2021-03-25
- Completion
- 2021-03-26
- First posted
- 2020-06-22
- Last updated
- 2022-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04441229. Inclusion in this directory is not an endorsement.